Abdominal MR Imaging at 3.0T: Sequence Optimization and Implementation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-12-15

Study Completion Date

2015-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project will facilitate the optimization of body MR imaging at 3 Tesla.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

T2 Weighted Imaging of the Liver With Fast Spin Echo MRI

NCT02186054

Liver Disease

TERMINATED NA

Liver Fat and Iron Quantification MRI

NCT03162302

Liver Diseases

COMPLETED

Toward an Automated Method of Abdominal Fat Segmentation of MR Images

NCT01228968

Obesity

COMPLETED

Test and Optimization of New Specific MRI Sequences on an Imager Dedicated to Research

NCT03674645

Magnetic Resonance Imaging Sequences

UNKNOWN NA

Refinement and Assessment of New Magnetic Resonance Imaging (MRI) Technologies for Vascular, Abdominal, and Pelvic Exams

NCT00738712

Healthy

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This project is meant to improve the image quality of multiple sequences at 3.0T applied to the abdominal and pelvic regions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diffuse and Focal Abnormalities of the Liver and Pancreas

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Body MRI healthy volunteers

Body MRI to optimize sequences in healthy individuals and in disorder subjects

Group Type OTHER

Body MR imaging

Intervention Type DEVICE

Body MR imaging will be performed to optimize sequences

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Body MR imaging

Body MR imaging will be performed to optimize sequences

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Body MR imaging performed to optimize sequences

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects between ages of 19 and 65
* Healthy volunteer subjects should not have any history of disease or symptoms - based on clinical history
* Subjects with an underlying disorder (diffuse and focal abnormalities of the liver and pancreas)

Exclusion Criteria

* Inability to provide informed consent
* A medical or contraindications that will prevent subjects from having a MRI
* Subjects with severe renal dysfunction or patients on dialysis

Minimum Eligible Age

19 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes